{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:59:07Z","timestamp":1762005547238,"version":"build-2065373602"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,5,4]],"date-time":"2016-05-04T00:00:00Z","timestamp":1462320000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008678","name":"University of Leipzig","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008678","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jctejournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical & Translational Endocrinology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.jcte.2016.05.001","type":"journal-article","created":{"date-parts":[[2016,5,5]],"date-time":"2016-05-05T19:18:05Z","timestamp":1462475885000},"page":"53-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["The chlorite-based drug WF10 constantly reduces hemoglobin A1c values and improves glucose control in diabetes patients with severe foot syndrome"],"prefix":"10.1016","volume":"4","author":[{"given":"Paiboon","family":"Maraprygsavan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jarasporn","family":"Mongkolsuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juergen","family":"Arnhold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Friedrich-Wilhelm","family":"Kuehne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcte.2016.05.001_bib0010","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s40257-014-0081-9","article-title":"Diabetic foot ulcer: an evidence-based treatment update","volume":"15","author":"Braun","year":"2014","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jcte.2016.05.001_bib0015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1753-0407.2009.00009.x","article-title":"Review of hemoglobin A1c in the management of diabetes","volume":"1","author":"Gallagher","year":"2009","journal-title":"J Diabetes"},{"key":"10.1016\/j.jcte.2016.05.001_bib0020","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1038\/jid.2011.176","article-title":"Hemoglobin A1c is a predictor of healing rate in diabetic wounds","volume":"131","author":"Christman","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jcte.2016.05.001_bib0025","first-page":"621","article-title":"Glycation as the glucose link to diabetic complications","volume":"100","author":"Gugliucci","year":"2000","journal-title":"J Am Osteopath Assoc"},{"key":"10.1016\/j.jcte.2016.05.001_bib0030","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2337\/diabetes.54.6.1615","article-title":"The pathophysiology of diabetic complications. A unifying mechanism","volume":"54","author":"Brownlee","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.jcte.2016.05.001_bib0035","first-page":"253","article-title":"Progressive impairment of erythrocyte deformability as indicator of microangiopathy in type 2 diabetes melittus","volume":"36","author":"Shin","year":"2007","journal-title":"Clin Hemorheol Microcirc"},{"key":"10.1016\/j.jcte.2016.05.001_bib0040","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3233\/CH-2009-1245","article-title":"Erythrocyte fragility with level of glycosylated hemoglobin in type 2 diabetic patients","volume":"43","author":"Kung","year":"2009","journal-title":"Clin Hemorheol Microcirc"},{"key":"10.1016\/j.jcte.2016.05.001_bib0045","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ejim.2011.11.004","article-title":"Erythrocyte mechanical fragility is increased in patients with type 2 diabetes","volume":"23","author":"Lippi","year":"2012","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jcte.2016.05.001_bib0050","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1001\/jama.293.13.1653","article-title":"The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin. A novel mechanism of human disease","volume":"293","author":"Rother","year":"2005","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.jcte.2016.05.001_bib0055","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1161\/01.HYP.31.5.1047","article-title":"Review of alterations in endothelial nitric oxide production in diabetes","volume":"31","author":"Pieper","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.jcte.2016.05.001_bib0060","doi-asserted-by":"crossref","first-page":"E14","DOI":"10.1161\/01.RES.88.2.e14","article-title":"Mechanisms underlying endothelial dysfunction in diabetes mellitus","volume":"88","author":"Hink","year":"2001","journal-title":"Circ Res"},{"issue":"Suppl. 1","key":"10.1016\/j.jcte.2016.05.001_bib0065","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1160\/THS10-11-0739","article-title":"Inflammation and thrombosis in diabetes","volume":"105","author":"Hess","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jcte.2016.05.001_bib0070","doi-asserted-by":"crossref","first-page":"115","DOI":"10.20452\/pamw.1201","article-title":"Novel pathway of iron-induced blood coagulation: implications for diabetes mellitus and its complications","volume":"122","author":"Lipinski","year":"2012","journal-title":"Pol Arch Med Wewn"},{"key":"10.1016\/j.jcte.2016.05.001_bib0075","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1475-2840-12-25","article-title":"Changes in red blood cell membrane structure in type 2 diabetes: a scanning electron and atomic force microscopy study","volume":"12","author":"Buys","year":"2013","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jcte.2016.05.001_bib0080","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1053\/j.jfas.2011.05.006","article-title":"Effect of WF10 (Immunokine) on diabetic foot ulcer therapy: a double-blind, randomized, placebo-controlled trail","volume":"50","author":"Yingsakmongkol","year":"2011","journal-title":"J Foot Ankle Surg"},{"key":"10.1016\/j.jcte.2016.05.001_bib0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12968\/jowc.2013.22.3.130","article-title":"Clinical outcome of WF10 adjunct to standard treatment of diabetic foot ulcers","volume":"22","author":"Yingsakmongkol","year":"2013","journal-title":"J Wound Care"},{"key":"10.1016\/j.jcte.2016.05.001_bib0090","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/01.ASW.0000358639.45784.cd","article-title":"The relationship between hemoglobin A(1c) values and healing time for lower extremity ulcers in individuals with diabetes","volume":"22","author":"Markuson","year":"2009","journal-title":"Adv Skin Wound Care"},{"key":"10.1016\/j.jcte.2016.05.001_bib0095","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3928\/0147-7447-19870101-28","article-title":"The diabetic foot","volume":"10","author":"Wagner","year":"1987","journal-title":"Orthopedics"},{"key":"10.1016\/j.jcte.2016.05.001_bib0100","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/BF02962364","article-title":"Randomized, double-blind, placebo-controlled trial of the immune modulator WF10 in patients with advanced AIDS","volume":"26","author":"Raffanti","year":"1998","journal-title":"Infection"},{"key":"10.1016\/j.jcte.2016.05.001_bib0105","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/S0026-0495(97)90216-X","article-title":"Polyol pathway activation and glutathione redox status in non-insulin-dependent diabetic patients","volume":"46","author":"Bravi","year":"1997","journal-title":"Metabolism"},{"key":"10.1016\/j.jcte.2016.05.001_bib0110","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/2251-6581-11-9","article-title":"Red blood cell ATP\/ADP & nitric oxide: the best vasodilators in diabetic patients","volume":"11","author":"Bahktiari","year":"2012","journal-title":"J Diabetes Metab Disord"},{"key":"10.1016\/j.jcte.2016.05.001_bib0115","doi-asserted-by":"crossref","first-page":"R125","DOI":"10.1186\/cc11425","article-title":"Free hemoglobin concentration in severe sepsis: methods of measurement and prediction of outcome","volume":"16","author":"Adamzik","year":"2012","journal-title":"Crit Care"},{"key":"10.1016\/j.jcte.2016.05.001_bib0120","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1182\/blood-2012-11-451229","article-title":"Hemolysis and hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins","volume":"121","author":"Schaer","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jcte.2016.05.001_bib0125","series-title":"Acute phase proteins \u2013 regulation and functions of acute phase proteins","first-page":"261","article-title":"Haptoglobin and hemopexin in heme detoxification and iron recycling","author":"Chiabrando","year":"2011"},{"key":"10.1016\/j.jcte.2016.05.001_bib0130","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1182\/blood.V100.3.879","article-title":"Pro-oxidant and cytotoxic effects of circulating heme","volume":"100","author":"Jeney","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jcte.2016.05.001_bib0135","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/mnfr.200500076","article-title":"Heme, heme oxygenase and ferritin in vascular endothelial cell injury","volume":"49","author":"Balla","year":"2005","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.jcte.2016.05.001_bib0140","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.toxlet.2005.03.004","article-title":"Free heme toxicity and its detoxification systems in human","volume":"157","author":"Kumar","year":"2005","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.jcte.2016.05.001_bib0145","first-page":"3","article-title":"Chlorite-hemoprotein interaction as key role for the pharmacological activity of the chlorite-based drug WF10","volume":"51","author":"Schempp","year":"2001","journal-title":"Drug Res"},{"key":"10.1016\/j.jcte.2016.05.001_bib0150","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jinorgbio.2007.09.002","article-title":"Mechanism of reaction of horseradish peroxidase with chlorite and chlorine dioxide","volume":"102","author":"Jakopitsch","year":"2008","journal-title":"J Inorg Biochem"},{"key":"10.1016\/j.jcte.2016.05.001_bib0155","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jinorgbio.2014.02.010","article-title":"Mechanism of reaction of chlorite with mammalian heme peroxidases","volume":"135","author":"Jakopitsch","year":"2014","journal-title":"J Inorg Biochem"},{"key":"10.1016\/j.jcte.2016.05.001_bib0160","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.abb.2015.09.009","article-title":"Interaction of the chlorite-based drug WF10 with hemoglobin, methemoglobin and ferryl hemoglobin","volume":"585","author":"Pichert","year":"2015","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.jcte.2016.05.001_bib0165","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1289\/ehp.824647","article-title":"Subchronic toxicity of chlorine dioxide and related compounds in drinking water in the nonhuman primate","volume":"46","author":"Bercz","year":"1982","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.jcte.2016.05.001_bib0170","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/jat.2550150306","article-title":"Potency ranking of methemoglobin-forming agents","volume":"15","author":"French","year":"1995","journal-title":"J Appl Toxicol"},{"key":"10.1016\/j.jcte.2016.05.001_bib0175","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/BF01736530","article-title":"Oxiferin und Natriumchlorit \u2013 Ein Vergleich","volume":"67","author":"Habermann","year":"1989","journal-title":"Klin Wochenschr"},{"key":"10.1016\/j.jcte.2016.05.001_bib0180","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/096032719201100311","article-title":"The interactive effect of chlorine, copper and nitrite on methemoglobin formation in red blood cells of Dorset sheep","volume":"11","author":"Langlois","year":"1992","journal-title":"Hum Exp Toxicol"},{"key":"10.1016\/j.jcte.2016.05.001_bib0185","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0006-2944(74)90061-1","article-title":"Effects of carboxyhemoglobin on the determination of methemoglobin in blood","volume":"9","author":"Rodkey","year":"1974","journal-title":"Biochem Med"},{"key":"10.1016\/j.jcte.2016.05.001_bib0190","doi-asserted-by":"crossref","first-page":"5760","DOI":"10.1021\/bi400405p","article-title":"Membrane peroxidation and methemoglobin formation are both necessary for band 3 protein clustering: mechanistic insights into human erythrocyte senescence","volume":"52","author":"Arashiki","year":"2013","journal-title":"Biochemistry"},{"key":"10.1016\/j.jcte.2016.05.001_bib0195","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1001\/archinte.168.15.1699","article-title":"The hemoglobin A1c level as a progressive risk factor for cardiovascular death, hospitalization for heart failure, or death in patients with chronic heart failure","volume":"168","author":"Gerstein","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jcte.2016.05.001_bib0200","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.2337\/dc11-0329","article-title":"Hemoglobin A1c, fasting glucose, and cardiovascular risk in a population with high prevalence of diabetes","volume":"34","author":"Wang","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcte.2016.05.001_bib0205","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.2337\/diacare.27.6.1259","article-title":"Biological variation in HbA1c predicts risk of retinopathy and nephropathy in type 1 diabetes","volume":"27","author":"McCarter","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcte.2016.05.001_bib0210","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/WNP.0b013e31819862ee","article-title":"Elevated glycosylated hemoglobin is associated with subclinical neuropathy in neurologically asymptomatic diabetic patients: a prospective study","volume":"26","author":"El-Salem","year":"2009","journal-title":"J Clin Neurophysiol"},{"key":"10.1016\/j.jcte.2016.05.001_bib0215","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/nm1202-799","article-title":"Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease","volume":"8","author":"Reiter","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.jcte.2016.05.001_bib0220","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.freeradbiomed.2003.11.030","article-title":"NO scavenging and the hypertensive effect of hemoglobin-based blood substitutes","volume":"36","author":"Olson","year":"2004","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jcte.2016.05.001_bib0225","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.2337\/diabetes.51.10.3095","article-title":"Nitric oxide prevents aldose reductase activation and sorbitol accumulation during diabetes","volume":"51","author":"Chandra","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.jcte.2016.05.001_bib0230","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0009-2797(02)00214-4","article-title":"Regulation of aldose reductase and the polyol pathway activity by nitric oxide","volume":"143\u2013144","author":"Srivastava","year":"2003","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.jcte.2016.05.001_bib0235","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1136\/bjo.86.12.1363","article-title":"Correlation between erythrocyte aldose reductase level and human diabetic retinopathy","volume":"86","author":"Oishi","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jcte.2016.05.001_bib0240","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1515\/CCLM.2003.194","article-title":"Obesity, glucose intolerance and diabetes and their links to cardiovascular disease. Implication for laboratory medicine","volume":"41","author":"Dominiczak","year":"2003","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jcte.2016.05.001_bib0245","doi-asserted-by":"crossref","first-page":"164","DOI":"10.2337\/diacare.28.1.164","article-title":"Diabetic nephropathy: diagnosis, prevention, and treatment","volume":"28","author":"Gross","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcte.2016.05.001_bib0250","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1161\/CIRCRESAHA.109.213447","article-title":"Aldose reductase and cardiovascular diseases, creating human-like diabetic complications in an experimental model","volume":"106","author":"Ramasamy","year":"2010","journal-title":"Circ Res"}],"container-title":["Journal of Clinical & Translational Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214623716300072?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214623716300072?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:53:23Z","timestamp":1762005203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214623716300072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":49,"alternative-id":["S2214623716300072"],"URL":"https:\/\/doi.org\/10.1016\/j.jcte.2016.05.001","relation":{},"ISSN":["2214-6237"],"issn-type":[{"type":"print","value":"2214-6237"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The chlorite-based drug WF10 constantly reduces hemoglobin A1c values and improves glucose control in diabetes patients with severe foot syndrome","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical & Translational Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcte.2016.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}